However, in patients with established atherosclerotic cardiovascular disease, high cardiovascular risk, or chronic kidney disease, they are now recommended as first-line therapy [22]
2 Search strategy and inclusion criteria This mini-review was based on a targeted literature search conducted in PubMed/MEDLINE and Scopus from January 2015 to August 2025, using the keywords GLP-1 receptor agonists, exercise, physical activity, obesity, type 2 diabetes, and weight loss. Additional terms ( lean mass, body composition, insulin sensitivity, cardiometabolic, combined intervention ) were used in secondary searches
Contact your account representative.
Novel tricyclic small molecule inhibitors of Nicotinamide N-methyltransferase for the treatment of metabolic disorders
(5/5) Glutathione supplement "I used it for a month and I'm not sure of the impact
Zheng S, Li W, Xu M, Bai X, Zhou Z, Han J, et al